Characterization of the Effect of N-(2-Methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, Compound 8, against Leishmania mexicana and Its In Vivo Leishmanicidal Activity

Chemotherapy currently available for leishmaniasis treatment has many adverse side effects and drug resistance. Therefore, the identification of new targets and the development of new drugs are urgently needed. Previously, we reported the synthesis of a N-(2-methoxyphenyl)-1-methyl-1H-benzimidazol-2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2024-01, Vol.25 (1), p.659
Hauptverfasser: Nieto-Meneses, Rocío, Castillo, Rafael, Hernández-Campos, Alicia, Nogueda-Torres, Benjamín, López-Villegas, Edgar Oliver, Moreno-Rodríguez, Adriana, Matadamas-Martínez, Félix, Yépez-Mulia, Lilián
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 659
container_title International journal of molecular sciences
container_volume 25
creator Nieto-Meneses, Rocío
Castillo, Rafael
Hernández-Campos, Alicia
Nogueda-Torres, Benjamín
López-Villegas, Edgar Oliver
Moreno-Rodríguez, Adriana
Matadamas-Martínez, Félix
Yépez-Mulia, Lilián
description Chemotherapy currently available for leishmaniasis treatment has many adverse side effects and drug resistance. Therefore, the identification of new targets and the development of new drugs are urgently needed. Previously, we reported the synthesis of a N-(2-methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, named compound 8, with an IC50 value in the micromolar range against L. mexicana, it also inhibited 68.27% the activity of recombinant L. mexicana arginase. Herein, we report studies carried out to characterize the mechanism of action of compound 8, as well as its in vivo leishmanicidal activity. It was shown in our ultrastructural studies that compound 8 induces several changes, such as membrane blebbing, the presence of autophagosomes, membrane detachment and mitochondrial and kinetoplast disorganization, among others. Compound 8 triggers the production of ROS and parasite apoptosis. It reduced 71% of the parasite load of L. mexicana in an experimental model of cutaneous leishmaniasis in comparison with a control. Altogether, the data obtained suggest the potential use of compound 8 in the treatment of cutaneous leishmaniasis.
doi_str_mv 10.3390/ijms25010659
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10779428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2912824137</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-6440a3eaa409c469694a266423881e2222df66c55ef99583ef4703453968f1243</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhiMEEmXhxg-wxKVIa-qvOPEJVatCV9rCBbhGU--k8Sq2l9hZNfuH-Jtk1QoKc5mvR6_e0RTFW84-SGnYhdv5JErGmS7Ns-KMKyEoY7p6_qR-WbxKaceYkKI0Z8WvVQcD2IyDO0J2MZDYktwhuWpbtPnUfaHngt5g7uL9tO8wTP17yqmfB1NP-TW9xXB03m3hGHsqKHgXcElW0e_jGLakXhK4AxdSJht0qfMQHBCP985CAAIzss6JrAP54Q7xL2NnxZ5c2uwOLk-vixct9AnfPOZF8f3T1bfVNd18_bxeXW6olarKVCvFQCKAYsYqbbRRILRWQtY1RzHHttXaliW2xpS1xFZVTKpSGl23XCi5KD4-6O7HW49biyEP0Df7wXkYpiaCa_7dBNc1d_HQcFZVRol6Vjh_VBjizxFTbrxLFvseAsYxNcJwqVRVzp4Wxbv_0F0chzDfd6JELRSX1UwtHyg7xJQGbP-44aw5_b15-nf5G1kpoRM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2912824137</pqid></control><display><type>article</type><title>Characterization of the Effect of N-(2-Methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, Compound 8, against Leishmania mexicana and Its In Vivo Leishmanicidal Activity</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Nieto-Meneses, Rocío ; Castillo, Rafael ; Hernández-Campos, Alicia ; Nogueda-Torres, Benjamín ; López-Villegas, Edgar Oliver ; Moreno-Rodríguez, Adriana ; Matadamas-Martínez, Félix ; Yépez-Mulia, Lilián</creator><creatorcontrib>Nieto-Meneses, Rocío ; Castillo, Rafael ; Hernández-Campos, Alicia ; Nogueda-Torres, Benjamín ; López-Villegas, Edgar Oliver ; Moreno-Rodríguez, Adriana ; Matadamas-Martínez, Félix ; Yépez-Mulia, Lilián</creatorcontrib><description>Chemotherapy currently available for leishmaniasis treatment has many adverse side effects and drug resistance. Therefore, the identification of new targets and the development of new drugs are urgently needed. Previously, we reported the synthesis of a N-(2-methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, named compound 8, with an IC50 value in the micromolar range against L. mexicana, it also inhibited 68.27% the activity of recombinant L. mexicana arginase. Herein, we report studies carried out to characterize the mechanism of action of compound 8, as well as its in vivo leishmanicidal activity. It was shown in our ultrastructural studies that compound 8 induces several changes, such as membrane blebbing, the presence of autophagosomes, membrane detachment and mitochondrial and kinetoplast disorganization, among others. Compound 8 triggers the production of ROS and parasite apoptosis. It reduced 71% of the parasite load of L. mexicana in an experimental model of cutaneous leishmaniasis in comparison with a control. Altogether, the data obtained suggest the potential use of compound 8 in the treatment of cutaneous leishmaniasis.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25010659</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Cytotoxicity ; Drug dosages ; Drug resistance ; Nanotechnology ; Parasites ; Parasitic diseases ; Polyamines ; Protozoa ; Tropical diseases</subject><ispartof>International journal of molecular sciences, 2024-01, Vol.25 (1), p.659</ispartof><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c347t-6440a3eaa409c469694a266423881e2222df66c55ef99583ef4703453968f1243</cites><orcidid>0000-0001-9564-7066 ; 0000-0001-8675-5671 ; 0000-0003-4609-6581 ; 0000-0002-9995-2145 ; 0000-0003-4100-8255 ; 0000-0003-4466-2340</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779428/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779428/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids></links><search><creatorcontrib>Nieto-Meneses, Rocío</creatorcontrib><creatorcontrib>Castillo, Rafael</creatorcontrib><creatorcontrib>Hernández-Campos, Alicia</creatorcontrib><creatorcontrib>Nogueda-Torres, Benjamín</creatorcontrib><creatorcontrib>López-Villegas, Edgar Oliver</creatorcontrib><creatorcontrib>Moreno-Rodríguez, Adriana</creatorcontrib><creatorcontrib>Matadamas-Martínez, Félix</creatorcontrib><creatorcontrib>Yépez-Mulia, Lilián</creatorcontrib><title>Characterization of the Effect of N-(2-Methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, Compound 8, against Leishmania mexicana and Its In Vivo Leishmanicidal Activity</title><title>International journal of molecular sciences</title><description>Chemotherapy currently available for leishmaniasis treatment has many adverse side effects and drug resistance. Therefore, the identification of new targets and the development of new drugs are urgently needed. Previously, we reported the synthesis of a N-(2-methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, named compound 8, with an IC50 value in the micromolar range against L. mexicana, it also inhibited 68.27% the activity of recombinant L. mexicana arginase. Herein, we report studies carried out to characterize the mechanism of action of compound 8, as well as its in vivo leishmanicidal activity. It was shown in our ultrastructural studies that compound 8 induces several changes, such as membrane blebbing, the presence of autophagosomes, membrane detachment and mitochondrial and kinetoplast disorganization, among others. Compound 8 triggers the production of ROS and parasite apoptosis. It reduced 71% of the parasite load of L. mexicana in an experimental model of cutaneous leishmaniasis in comparison with a control. Altogether, the data obtained suggest the potential use of compound 8 in the treatment of cutaneous leishmaniasis.</description><subject>Cytotoxicity</subject><subject>Drug dosages</subject><subject>Drug resistance</subject><subject>Nanotechnology</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>Polyamines</subject><subject>Protozoa</subject><subject>Tropical diseases</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU1v1DAQhiMEEmXhxg-wxKVIa-qvOPEJVatCV9rCBbhGU--k8Sq2l9hZNfuH-Jtk1QoKc5mvR6_e0RTFW84-SGnYhdv5JErGmS7Ns-KMKyEoY7p6_qR-WbxKaceYkKI0Z8WvVQcD2IyDO0J2MZDYktwhuWpbtPnUfaHngt5g7uL9tO8wTP17yqmfB1NP-TW9xXB03m3hGHsqKHgXcElW0e_jGLakXhK4AxdSJht0qfMQHBCP985CAAIzss6JrAP54Q7xL2NnxZ5c2uwOLk-vixct9AnfPOZF8f3T1bfVNd18_bxeXW6olarKVCvFQCKAYsYqbbRRILRWQtY1RzHHttXaliW2xpS1xFZVTKpSGl23XCi5KD4-6O7HW49biyEP0Df7wXkYpiaCa_7dBNc1d_HQcFZVRol6Vjh_VBjizxFTbrxLFvseAsYxNcJwqVRVzp4Wxbv_0F0chzDfd6JELRSX1UwtHyg7xJQGbP-44aw5_b15-nf5G1kpoRM</recordid><startdate>20240104</startdate><enddate>20240104</enddate><creator>Nieto-Meneses, Rocío</creator><creator>Castillo, Rafael</creator><creator>Hernández-Campos, Alicia</creator><creator>Nogueda-Torres, Benjamín</creator><creator>López-Villegas, Edgar Oliver</creator><creator>Moreno-Rodríguez, Adriana</creator><creator>Matadamas-Martínez, Félix</creator><creator>Yépez-Mulia, Lilián</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9564-7066</orcidid><orcidid>https://orcid.org/0000-0001-8675-5671</orcidid><orcidid>https://orcid.org/0000-0003-4609-6581</orcidid><orcidid>https://orcid.org/0000-0002-9995-2145</orcidid><orcidid>https://orcid.org/0000-0003-4100-8255</orcidid><orcidid>https://orcid.org/0000-0003-4466-2340</orcidid></search><sort><creationdate>20240104</creationdate><title>Characterization of the Effect of N-(2-Methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, Compound 8, against Leishmania mexicana and Its In Vivo Leishmanicidal Activity</title><author>Nieto-Meneses, Rocío ; Castillo, Rafael ; Hernández-Campos, Alicia ; Nogueda-Torres, Benjamín ; López-Villegas, Edgar Oliver ; Moreno-Rodríguez, Adriana ; Matadamas-Martínez, Félix ; Yépez-Mulia, Lilián</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-6440a3eaa409c469694a266423881e2222df66c55ef99583ef4703453968f1243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cytotoxicity</topic><topic>Drug dosages</topic><topic>Drug resistance</topic><topic>Nanotechnology</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>Polyamines</topic><topic>Protozoa</topic><topic>Tropical diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nieto-Meneses, Rocío</creatorcontrib><creatorcontrib>Castillo, Rafael</creatorcontrib><creatorcontrib>Hernández-Campos, Alicia</creatorcontrib><creatorcontrib>Nogueda-Torres, Benjamín</creatorcontrib><creatorcontrib>López-Villegas, Edgar Oliver</creatorcontrib><creatorcontrib>Moreno-Rodríguez, Adriana</creatorcontrib><creatorcontrib>Matadamas-Martínez, Félix</creatorcontrib><creatorcontrib>Yépez-Mulia, Lilián</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nieto-Meneses, Rocío</au><au>Castillo, Rafael</au><au>Hernández-Campos, Alicia</au><au>Nogueda-Torres, Benjamín</au><au>López-Villegas, Edgar Oliver</au><au>Moreno-Rodríguez, Adriana</au><au>Matadamas-Martínez, Félix</au><au>Yépez-Mulia, Lilián</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of the Effect of N-(2-Methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, Compound 8, against Leishmania mexicana and Its In Vivo Leishmanicidal Activity</atitle><jtitle>International journal of molecular sciences</jtitle><date>2024-01-04</date><risdate>2024</risdate><volume>25</volume><issue>1</issue><spage>659</spage><pages>659-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Chemotherapy currently available for leishmaniasis treatment has many adverse side effects and drug resistance. Therefore, the identification of new targets and the development of new drugs are urgently needed. Previously, we reported the synthesis of a N-(2-methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, named compound 8, with an IC50 value in the micromolar range against L. mexicana, it also inhibited 68.27% the activity of recombinant L. mexicana arginase. Herein, we report studies carried out to characterize the mechanism of action of compound 8, as well as its in vivo leishmanicidal activity. It was shown in our ultrastructural studies that compound 8 induces several changes, such as membrane blebbing, the presence of autophagosomes, membrane detachment and mitochondrial and kinetoplast disorganization, among others. Compound 8 triggers the production of ROS and parasite apoptosis. It reduced 71% of the parasite load of L. mexicana in an experimental model of cutaneous leishmaniasis in comparison with a control. Altogether, the data obtained suggest the potential use of compound 8 in the treatment of cutaneous leishmaniasis.</abstract><cop>Basel</cop><pub>MDPI AG</pub><doi>10.3390/ijms25010659</doi><orcidid>https://orcid.org/0000-0001-9564-7066</orcidid><orcidid>https://orcid.org/0000-0001-8675-5671</orcidid><orcidid>https://orcid.org/0000-0003-4609-6581</orcidid><orcidid>https://orcid.org/0000-0002-9995-2145</orcidid><orcidid>https://orcid.org/0000-0003-4100-8255</orcidid><orcidid>https://orcid.org/0000-0003-4466-2340</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2024-01, Vol.25 (1), p.659
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10779428
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Cytotoxicity
Drug dosages
Drug resistance
Nanotechnology
Parasites
Parasitic diseases
Polyamines
Protozoa
Tropical diseases
title Characterization of the Effect of N-(2-Methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine, Compound 8, against Leishmania mexicana and Its In Vivo Leishmanicidal Activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T14%3A17%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20the%20Effect%20of%20N-(2-Methoxyphenyl)-1-methyl-1H-benzimidazol-2-amine,%20Compound%208,%20against%20Leishmania%20mexicana%20and%20Its%20In%20Vivo%20Leishmanicidal%20Activity&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Nieto-Meneses,%20Roc%C3%ADo&rft.date=2024-01-04&rft.volume=25&rft.issue=1&rft.spage=659&rft.pages=659-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25010659&rft_dat=%3Cproquest_pubme%3E2912824137%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2912824137&rft_id=info:pmid/&rfr_iscdi=true